McCormick Reports Strong 2025 Results, Raises Dividend, and Projects Double-Digit 2026 Growth
Summary
McCormick & Company reported strong Q4 and full-year 2025 financial results, with modest organic sales growth and adjusted EPS increases. The company also provided a positive 2026 outlook, projecting significant sales and operating income growth driven by an acquisition, and announced its 40th consecutive annual dividend increase.
Key Events
-
Q4 2025 Performance
Net sales increased 3% (2% organic), and adjusted diluted EPS grew 7.5% to $0.86 compared to the prior year period.
-
Full Year 2025 Performance
Net sales increased 2% (2% organic), adjusted diluted EPS grew 1.7% to $3.00, and cash flow from operations was strong at $962 million.
-
Dividend Increase
The Board authorized a 7% increase to the quarterly dividend, marking the 40th consecutive year of dividend increases.
-
Fiscal Year 2026 Outlook
The company projects reported net sales growth of 13-17% and adjusted operating income growth of 16-20%, largely driven by the McCormick de Mexico acquisition. Adjusted diluted EPS is expected to grow 2-5%.
Analysis
McCormick's latest 8-K filing details a solid close to fiscal year 2025 and a promising outlook for 2026, which could be a positive catalyst given the stock's current position near its 52-week low. While organic sales growth for 2025 was modest at 2%, the company's adjusted EPS saw a healthy 7.5% increase in Q4. The most significant takeaway is the robust 2026 outlook, projecting double-digit reported sales and operating income growth, primarily fueled by the recent acquisition of a controlling interest in McCormick de Mexico. This strategic move is expected to drive top-line expansion and operating margin recovery. Furthermore, the announcement of a 7% dividend increase, marking the 40th consecutive year, underscores management's confidence in future cash flow generation and commitment to shareholder returns. Investors should monitor the integration of the McCormick de Mexico acquisition and the company's ability to mitigate ongoing cost headwinds to achieve its ambitious 2026 targets.
At the time of this filing, MKC was trading at $62.51 on NYSE in the Manufacturing sector, with a market capitalization of approximately $17.9B. The 52-week trading range was $62.64 to $86.24. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.